Business
Why the Mesoblast (ASX:MSB) share price is charging higher today – The Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is pushing higher on Monday after providing an update on its remestemcel-L for the treatment of SR-aGVHD…
The Mesoblast limited(ASX: MSB) share price has started the week strongly and is charging higher.
In early trade the allogeneic cellular medicines company’s shares are up 3% to $4.45.
Why is the Mesoblast share price pushing higher?
Investors have been buying the company’s shares this morning after its revealed results from a study of its remestemcel-L product in children with steroid-refractory acute graft versus host disease (SR-aGVHD).
According to the release, the results provide in vivo biomarker…
-
Noosa News18 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General17 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News9 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General6 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania